When you or someone you love is diagnosed with Parkinson’s disease, the search for help begins immediately. You talk to other people with Parkinson’s. You join support groups. You ask your neurologist. You search online. And over time, a list of recommendations begins to take shape including exercise programs, speech therapy, physical therapy, occupational therapy, nutrition, medications, and more.
But not all therapy treatments are backed by the same quality of science. Some approaches have been rigorously tested in large clinical trials, increasing confidence in their effectiveness. Others are popular, well-marketed, and widely recommended, but the evidence behind them is limited or preliminary.
Unlike programs that may be described as “clinically proven,” it’s important to recognize that “scientifically-proven” through clinical trials strengthen the likelihood of benefit, although they don’t guarantee outcomes for every individual. The difference matters, and being aware of it can guide better decisions.
This guide will help you ask better questions, understand what “evidence-based” really means, and become your own best advocate for receiving the most effective care available.
What Does “Evidence-Based” Actually Mean?
You’ve probably heard this phrase. But what does it mean in practice?
In healthcare, “evidence-based” means that a treatment has been carefully tested in scientific research, usually in studies called randomized controlled trials (RCTs), and shown to produce real, measurable benefits for people with conditions like yours. The best evidence comes from multiple independent studies that reach the same conclusions, often compiled into what researchers call a systematic review or meta-analysis. “Evidence-informed” means that research is used as a guide, but the specific treatment itself has not been researched.
Compare that to treatments that are recommended based on:
- What worked for someone else in your support group
- What your neighbor’s therapist suggested
- What a therapist learned at a recent weekend workshop
- What feels intuitive or popular right now
None of these are necessarliy bad advice. But personal experience, even from doctors and therapists, is not the same as scientific evidence. Parkinson’s affects every person differently, and what helped one person may not help you. What we need to know is: what works for most people, most of the time, when tested rigorously?
“Evidence-based practice” doesn’t mean cold or impersonal care. It means your therapist is using treatments that science has shown are most likely to help you, not just treatments that seem reasonable or that other people have tried.
Why Exploration of Evidence is Beneficial
Parkinson’s support communities are genuinely wonderful. The shared experience, emotional support, and practical wisdom in these groups are irreplaceable, and you can learn a tremendous amount from others who have “been there.” At the same time, because treatment experiences can vary so much from person to person, it is worth the extra effort to explore the evidence behind any recommendations you hear and discuss them with your healthcare team. Here’s why:
- Parkinson’s is highly individual. Two people with the same diagnosis can respond very differently to the same treatment. Someone else’s success story does not predict your outcome.
- Placebo effects are real. When people try something new with hope and enthusiasm, they often feel better, at least briefly. Clinical trials are specifically designed to separate real treatment effects from this natural optimism.
- Physicians are not always fully up to date on every aspect of therapy research. Your neurologist may be an exceptional clinician and still not be familiar with which specific therapy protocols currently have the strongest evidence. Their training focuses heavily on diagnosis and medication management, so collaboration with rehabilitation specialists can be especially valuable.
- Popularity is not the same as effectiveness. A treatment can be widely used, heavily marketed, and genuinely beloved by its practitioners, and still lack rigorous evidence of efficacy.
Support groups are a great place to learn about new medications and therapies, but most people still rely on their healthcare team to decide what’s appropriate for them. Your therapy deserves that same kind of careful collaboration and evidence-based support.
Real Examples: What the Evidence Actually Shows
Let’s make this concrete. Here are a few well-researched therapy approaches for Parkinson’s, along with what the science says.
For Your Voice: LSVT LOUD®
Many people with Parkinson’s gradually speak more softly and less clearly, a condition called hypophonia. LSVT LOUD (Lee Silverman Voice Treatment) is an intensive, one-on-one speech therapy program that has been tested for over 30 years in randomized controlled trials by both its developers and independent research teams worldwide. The quality of these studies qualifies them to be included in systematic reviews and meta-analyses.
The evidence is strong: vocal loudness, speech clarity, and communicative participation all improve significantly, with benefits documented up to two years after treatment (Ramig et al., 2001; Levy et al., 2020; Pu et al., 2021).
Brain imaging studies show measurable changes in the speech motor network, not just behavioral improvements (Narayana et al., 2022). For those who can’t access in-person care, video-based treatment delivery has been validated as equally effective (Theodoros et al., 2016).
LSVT LOUD follows a specific protocol: four sessions per week for four weeks, with a certified therapist. The intensity is not optional, it is part of why it works.
For Your Movement: LSVT BIG®
LSVT BIG applies the same principles to movement, targeting the symptoms of bradykinesia and hypokinesia, which cause people with PD to move smaller and slower. A randomized controlled trial found it produced greater improvements in motor function than conventional physical therapy (Ebersbach et al., 2010), and several systematic reviews and meta-analyses confirmed significant benefits across multiple studies (McDonnell et al., 2018; Alashram, 2025; Luna et al., 2025).
Research also shows improvements in gait speed, balance, mood, and quality of life, with gains that can be retained long-term with home practice (Millage et al., 2017; Fleming Walsh et al., 2022).
Like LSVT LOUD, the LSVT BIG protocol matters. Intensity, frequency, and delivery by certified therapists are part of what produces the outcomes seen in research.
For Exercise: High-Intensity and Aerobic Training
A growing body of research, including a major NIH-funded trial SPARX2 (Schenkman et al., 2018), supports high-intensity treadmill exercise as beneficial for motor symptoms in Parkinson’s. Other exercise programs have enthusiastic communities and some emerging research, but not all have rigorous large-scale trial evidence. That doesn’t mean they’re ineffective, it means the evidence base is still developing.
Knowing the difference between “we have strong evidence” and “this looks promising and people enjoy it” is exactly the kind of nuance that will help you make better decisions.
Questions to Ask Your Therapist
It is both reasonable and empowering to ask your speech, physical, or occupational therapist questions. Questions can open up a thoughtful dialogue about your care. Many therapists appreciate these questions because they support shared decision-making.
“What treatment approach are you recommending for me, and what is the evidence behind it?” Listen for references to research studies, clinical trials, or systematic reviews. Experimental or emerging treatments can be appropriate and even helpful, as long as there is transparency about the level of evidence so you can make an informed choice. Be cautious if the answer is primarily about personal experience, colleague recommendations, or anecdote.
“Has this treatment been specifically tested in people with Parkinson’s disease?” Evidence in one population doesn’t always transfer to another. Ask specifically.
“Are there other approaches with stronger or more established evidence that I should know about?” A therapist committed to your best interests will be willing to discuss alternatives, even if they aren’t trained in them.
“Are you certified or specifically trained in this treatment, and does it matter for the results?” For treatments like LSVT LOUD and LSVT BIG, adherence to the protocol, including intensity, frequency, and certified delivery, is part of what produces the outcomes seen in research.
“How will we know if it’s working?” Therapists should be using evidence-based outcome measures and be able to share how your progress will be tracked to determine effectiveness.
How to Research a Treatment Yourself
You don’t need a science background to look into a treatment. Here are some practical steps:
- Start with trusted organizations. The Parkinson’s Foundation (parkinson.org) and the Michael J. Fox Foundation (michaeljfox.org) publish plain-language summaries of treatment evidence. These are a great first stop — they do the hard work of sorting through research so you don’t have to.
- If you want to dig deeper, try PubMed (pubmed.ncbi.nlm.nih.gov). Type the treatment name and “Parkinson’s” and see what comes up. Look for phrases like “clinical trial,” “randomized controlled trial,” or “systematic review” — these signal stronger, more rigorous evidence.
- Pay attention to how much evidence exists. A single small, early study is different from multiple large, independent trials reaching the same conclusion. Early evidence isn’t bad — it just calls for a bit more caution.
- Look for honesty about what’s unknown. Trustworthy descriptions of treatments will usually say what is known, what’s still being studied, and where questions remain. Phrases like “emerging evidence” or “early-stage research” are a sign of transparency, not a red flag.
- Be thoughtful about testimonials. Compelling personal stories can be a useful starting point, but they are not the same as research. Treat them as one piece of information, not the final answer.
You Are Your Own Best Advocate
Navigating day-to-day life with Parkinson’s is not easy. The last thing anyone should have to worry about is whether the time, money, and effort they invest in therapy are truly helping.
Research suggests that, for many reasons, therapists may not always deliver the treatments with the strongest evidence behind them. Factors like institutional pressures, limited access to training, and long-standing practice patterns can all play a role. This is an issue for the healthcare system and professions to keep improving, but in the meantime, you can still take steps to feel more confident and informed in your care.
You can ask questions, learn about the evidence, and look for therapists who are trained in evidence-based protocols and willing to explain the research in clear, understandable terms.
These conversations are not being “difficult”—they are part of being an engaged partner in your own care, which many clinicians genuinely value.
Parkinson’s is relentless, but rehabilitation science is continually evolving. You deserve to be informed about therapy and exercise options that are most strongly supported by this scientific research so you can benefit to the fullest extent in your daily life.
You would want the same standard of care for someone you love. You deserve it too.
Helpful Resources
- Parkinson’s Foundation — Evidence summaries, care recommendations, and a helpline (1-800-4PD-INFO)
- Michael J. Fox Foundation — Research updates and clinical trial information
- LSVT Global (LSVT LOUD & LSVT BIG) — Find certified therapists near you
- PubMed — Free access to medical research
- PMD Alliance — Education, support groups, and community resources
- ASHA Evidence Maps — Searchable evidence summaries for speech-language pathology
- PD EDGE — Searchable evidence resources for Parkinson’s physical & occupational therapy
References
Ramig, L., Sapir, S., Countryman, S., Pawlas, A., O’Brien, C., Hoehn, M., & Thompson, L. (2001). Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: A 2 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry, 71(4), 493–498. http://doi.org/10.1136/jnnp.71.4.493
Levy, E., Moya-Galé, G., Chang, Y., Freeman, K., Forrest, K., Brin, M. F., & Ramig, L.A. (2020). The effects of intensive speech treatment on intelligibility in Parkinson’s disease: A randomised controlled trial. The Lancet’s EClinicalMedicine, 24, 1–11. https://doi.org/10.1016/j.eclinm.2020.100429
Pu, T., Huang, M., Kong, X., Wang, M., Chen, X., Feng, X., Wei, C., Weng, X., & Xu, F. (2021). Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis. Parkinson’s Disease, 2021, 1–10. https://doi.org/10.1155/2021/3366870
Narayana, S., Franklin, C., Peterson, E., Hunter, E. J., Robin, D. A., Halpern, A., Spielman, J., Fox, P. T., & Ramig, L. O. (2022). Immediate and long‐term effects of speech treatment targets and intensive dosage on Parkinson’s disease dysphonia and the speech motor network: Randomized controlled trial. Human Brain Mapping, 43(7), 2328–2347. https://doi.org/10.1002/hbm.25790
Theodoros, D. G., Hill, A. J., & Russell, R. G. (2016). Clinical and quality of life outcomes of speech treatment for Parkinson’s disease delivered to the home via telerehabilitation: A noninferiority randomized controlled trial. American Journal of Speech-Language Pathology, 25(2), 214–232. https://doi.org/10.1044/2015_ajslp-15-0005
Ebersbach, G., Ebersbach, A., Edler, D., Kaufhold, O., Kusch, M., Kupsch, A., & Wissel, J. (2010). Comparing exercise in Parkinson’s disease–The Berlin LSVT® BIG study. Movement Disorders, 25(12), 1902-1908. https://doi.org/10.1002/mds.23212
McDonnell, M. N., Rischbieth, B., Schammer, T. T., Seaforth, C., Shaw, A. J., & Phillips, A. C. (2018). Lee Silverman Voice Treatment (LSVT) BIG to improve motor function in people with Parkinson’s disease: A systematic review and meta-analysis. Clinical Rehabilitation, 32(5), 607-618. https://doi.org/10.1177/0269215517734385
Alashram, A. R. (2025). Effects of Lee Silverman Voice Treatment® BIG on motor symptoms in patients with Parkinson’s disease: a systematic review and meta-analysis. Disability and Rehabilitation, 1–17. https://doi.org/10.1080/09638288.2025.2603171
Luna, G., Pardo-Cocuy, L. F., Garzón, A., Benítez-Ospina, A., & Parada-Gereda, H. M. (2025). Effectiveness of Lee Silverman Voice Treatment for Improving Motor Function in Patients With Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Clinical Trials. American journal of physical medicine & rehabilitation, 104(12), 1105–1112. https://doi.org/10.1097/PHM.0000000000002751
Millage, B., Vesey, E., Finkelstein, M., & Anheluk, M. (2017). Effect on gait speed, balance, motor symptom rating, and quality of life in those with stage I Parkinson’s disease utilizing LSVT BIG®. Rehabilitation Research and Practice, 2017. https://doi.org/10.1155/2017/9871070
Fleming Walsh, S., Balster, C., Chandler, A., Brown, J., Boehler, M., & O’Rear, S. (2022). LSVT BIG® and long-term retention of functional gains in individuals with Parkinson’s disease. Physiotherapy theory and practice, 38(5), 629–636. https://doi.org/10.1080/09593985.2020.1780655
Schenkman M, Moore CG, Kohrt WM, et al. Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. (2018). JAMA Neurol. 75(2):219–226. doi:10.1001/jamaneurol.2017.3517